好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

SNT-MC17/Idebenone in the Treatment of Friedreich's Ataxia: Initial Safety Data of a 6-Month US Phase 3 Clinical Study
Movement Disorders
(-)
008
Authors/Disclosures
David R. Lynch, MD, PhD (Children's Hospital of Philadelphia) The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Susan L. Perlman, MD (UCLA) Dr. Perlman has nothing to disclose.
Geoffrey L. Holder, MD (Santhera Pharmaceuticals) No disclosure on file
Thomas Meier, PhD (Santhera Pharmaceuticals) No disclosure on file
Subhash Tummala, MD No disclosure on file
No disclosure on file